indazoles has been researched along with Choroid Neovascularization in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 8 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haniuda, H; Horita, S; Kagawa, Y; Katagiri, M; Nakamura, H; Nakazato, T; Watanabe, M | 1 |
| Craven, C; Grossniklaus, HE; Kompella, U; Matter, B; Olsen, TW; Schmit, J; Tran, J; Wabner, K | 1 |
| Fukuda, R; Gotoh, N; Hashida, M; Hashida, Y; Murakami, T; Suda, K; Tsujikawa, A; Yoshimura, N | 1 |
| Danis, R; Johnson, MW; Kim, RY; McLaughlin, MM; Staurenghi, G; Tolentino, M; Xu, CF; Ye, L | 1 |
| Eswaraka, J; Giddabasappa, A; Gukasyan, HJ; Klamerus, K; Lalwani, K; Mosyak, L; Norberg, R; Paterson, D; Rittenhouse, K; Schachar, RA | 1 |
| Eibl-Lindner, K; Liegl, R; Priglinger, C; Priglinger, S; Siedlecki, J; Wertheimer, C; Wolf, A | 1 |
| Campochiaro, PA; King, AG; Levin, R; Saishin, Y; Takahashi, K | 1 |
| Cho, WK; Choi, HS; Kang, S; Kim, SH; Park, KC; Roh, CR; Roh, YJ; Yang, KJ | 1 |
| Adamson, P; Bainbridge, JW; Coffey, P; Ju, M; King, AG; Lange, CA; Lee, D; Lundh von Leithner, P; Ng, YS; Robbie, SJ; Shima, DT; Sychterz, C | 1 |
| Chung, H; Song, SJ; Yu, HG | 1 |
1 trial(s) available for indazoles and Choroid Neovascularization
| Article | Year |
|---|---|
Pazopanib eye drops: a randomised trial in neovascular age-related macular degeneration.
Topics: Angiogenesis Inhibitors; Choroidal Neovascularization; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Indazoles; Macular Degeneration; Male; Middle Aged; Ophthalmic Solutions; Prospective Studies; Pyrimidines; Sulfonamides; Treatment Outcome; Visual Acuity | 2014 |
9 other study(ies) available for indazoles and Choroid Neovascularization
| Article | Year |
|---|---|
Species differences in ocular pharmacokinetics and pharmacological activities of regorafenib and pazopanib eye-drops among rats, rabbits and monkeys.
Topics: Angiogenesis Inhibitors; Animals; Choroidal Neovascularization; Crystallization; Disease Models, Animal; Drug Evaluation, Preclinical; Eye; Female; Humans; Indazoles; Macaca fascicularis; Macular Degeneration; Male; Nanoparticles; Ophthalmic Solutions; Particle Size; Phenylurea Compounds; Pyridines; Pyrimidines; Rabbits; Rats; Receptors, Vascular Endothelial Growth Factor; Species Specificity; Sulfonamides; Vascular Endothelial Growth Factor A | 2019 |
A Pharmacodynamic Analysis of Choroidal Neovascularization in a Porcine Model Using Three Targeted Drugs.
Topics: Angiogenesis Inhibitors; Animals; Bevacizumab; Choroidal Neovascularization; Disease Models, Animal; Fluorescein Angiography; Immunoconjugates; Indazoles; Intravitreal Injections; Pyrimidines; Sulfonamides; Swine; T-Lymphocytes, Cytotoxic; Vascular Endothelial Growth Factor A | 2017 |
High-density lipoprotein mutant eye drops for the treatment of posterior eye diseases.
Topics: Angiogenesis Inhibitors; Animals; Apolipoprotein A-I; Cell-Penetrating Peptides; Choroidal Neovascularization; Coumarins; Drug Carriers; Indazoles; Lipoproteins, HDL; Liposomes; Male; Mice, Inbred C57BL; Mutation; Nanoparticles; Ophthalmic Solutions; Pyrimidines; Sulfonamides; Thiazoles | 2017 |
Axitinib inhibits retinal and choroidal neovascularization in in vitro and in vivo models.
Topics: Aged; Animals; Axitinib; Cell Proliferation; Choroidal Neovascularization; Disease Models, Animal; Endothelial Cells; Fluorescein Angiography; Humans; Imidazoles; Immunohistochemistry; Indazoles; Intravitreal Injections; Male; Mesenchymal Stem Cells; Pericytes; Protein Kinase Inhibitors; Rats | 2016 |
Combined VEGF and PDGF inhibition for neovascular AMD: anti-angiogenic properties of axitinib on human endothelial cells and pericytes in vitro.
Topics: Axitinib; Cell Proliferation; Cell Survival; Cells, Cultured; Choroidal Neovascularization; Endothelium, Vascular; Humans; Imidazoles; Indazoles; Macular Degeneration; Pericytes; Platelet-Derived Growth Factor; Protein Kinase Inhibitors; Signal Transduction; Vascular Endothelial Growth Factor A | 2017 |
Suppression and regression of choroidal neovascularization by the multitargeted kinase inhibitor pazopanib.
Topics: Administration, Oral; Angiogenesis Inhibitors; Animals; Biological Availability; Choroid; Choroidal Neovascularization; Chromatography, High Pressure Liquid; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Indazoles; Mice; Mice, Inbred C57BL; Protein Kinase Inhibitors; Pyrimidines; Retina; Sulfonamides; Tissue Distribution | 2009 |
Antiangiogenic effects of axitinib, an inhibitor of vascular endothelial growth factor receptor tyrosine kinase, on laser-induced choroidal neovascularization in mice.
Topics: Animals; Axitinib; Choroid; Choroidal Neovascularization; Disease Models, Animal; Imidazoles; Indazoles; Laser Coagulation; Male; Mice; Mice, Inbred C57BL; Microscopy, Confocal; Protein Kinase Inhibitors; Treatment Outcome; Vascular Endothelial Growth Factor Receptor-1 | 2013 |
Assessing a novel depot delivery strategy for noninvasive administration of VEGF/PDGF RTK inhibitors for ocular neovascular disease.
Topics: Administration, Oral; Administration, Topical; Angiogenesis Inhibitors; Animals; Autoradiography; Choroidal Neovascularization; Drug Delivery Systems; Female; Fluorescein Angiography; Half-Life; Indazoles; Melanins; Mice; Mice, Inbred C57BL; Microscopy, Confocal; Pyrimidines; Rats; Rats, Long-Evans; Rats, Sprague-Dawley; Receptors, Platelet-Derived Growth Factor; Sulfonamides; Sulfones; Uvea; Vascular Endothelial Growth Factor Receptor-1 | 2013 |
Inhibitory effect of YC-1, 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole, on experimental choroidal neovascularization in rat.
Topics: Angiogenesis Inhibitors; Animals; Choroidal Neovascularization; Female; Fluorescein Angiography; Fluorescent Antibody Technique; Fundus Oculi; Hypoxia-Inducible Factor 1; Indazoles; Laser Coagulation; Rats; Rats, Inbred BN; Staining and Labeling; Vascular Endothelial Growth Factor A | 2008 |